Title: Prevalence of frailty among patients with inflammatory bowel disease and its association
with clinical outcomes: a systematic review and meta-analysis.
Version: 5 Date: 25 Nov 2022
Reviewer's report:
The authors have revised the manuscript well. The abstract should denote the  hazard rates of
outcomes like mortality and hospitalisation as they were the outcomes of this meta-analysis  .
It would be better if the primary and secondary outcomes are depicted in clear subheadings.
Title: Prevalence of frailty among patients with inflammatory bowel disease and its association
with clinical outcomes: a systematic review and meta-analysis.
Version: 5 Date: 25 Nov 2022
Reviewer's report:
The authors have revised the manuscript well. The abstract should denote the  hazard rates of
outcomes like mortality and hospitalisation as they were the outcomes of this meta-analysis  .
It would be better if the primary and secondary outcomes are depicted in clear subheadings.
Please review this paper.
user
Title: Prevalence of frailty among patients with inflammatory bowel disease and its association
with clinical outcomes: a systematic review and meta-analysis.
Version: 5 Date: 25 Nov 2022
Reviewer's report:
The authors have revised the manuscript well. The abstract should denote the  hazard rates of
outcomes like mortality and hospitalisation as they were the outcomes of this meta-analysis  .
It would be better if the primary and secondary outcomes are depicted in clear subheadings.
assistant